Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Enhanced Plaque Removal in Peripheral Artery Disease

By HospiMedica staff writers
Posted on 02 Jan 2008
Two new devices are among the latest in plaque excision technology, designed to treat lesions in arteries above the knee for patients suffering from peripheral artery disease (PAD). More...


The SilverHawk LS-M and the SilverHawk MS-M catheters utilize a tiny rotating blade to shave plaque from artery walls and a reservoir nosecone to collect the excised plaque from the patient. The two new catheters include micro efficient compression (MEC) technology, which includes precision laser-drilled vent holes in the tip of the catheter. The micro vent holes release fluid pressure, providing more space for the collection of tissue in the tip of the device. The new technology has the potential to reduce overall procedure time, by enabling physicians to increase tissue collection during plaque removal procedures in large vessels above the knee. In vitro bench test results have demonstrated up to a 30% increase in tissue capture per insertion compared to other SilverHawk devices. The new devices are part of the SilverHawk plaque excision system, manufactured by ev3 (Plymouth, MN, USA).

"The SilverHawk LS-M and MS-M will allow physicians to treat patients more efficiently in plaque removal procedures for patients suffering from PAD,” said Jim Corbett, chairman and CEO of ev3. "The design of these devices, along with unique MEC Technology, is expected to be the workhorse for above the knee procedures. We are committed to providing the necessary tools for physicians to continue to move patient treatments forward and are excited to be able to provide this latest advancement in PAD care.”

PAD is a condition that occurs when plaque accumulates in the arteries and blocks blood flow in the legs. These blockages can result in severe leg pain, very limited physical mobility, and ultimately, can lead to amputation.


Related Links:
ev3

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.